<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>Hepatitis D Market Research Report 2023-2035 | Gilead, GSK, and Janssen Drive Innovation as Biotechs Advance Antivirals, RNA, and Gene Therapies</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>Hepatitis D Market Research Report 2023-2035 | Gilead, GSK, and Janssen Drive Innovation as Biotechs Advance Antivirals, RNA, and Gene Therapies</h1>
  <ul>
<li>Global Hepatitis D Market (by Diagnostic Methods), Value ($million), 2023-2035 3.1 Blood Tests 3.2 Imaging Techniques 4.</li>
<li>4.1.3.2 Canada 4.2 Europe 4.2.1 Market Dynamics 4.2.2 Market Sizing and Forecast 4.2.3 Europe Hepatitis D Market, by Country ($Million), 2023-2035 4.2.3.1 U.K.</li>
<li>Global Hepatitis D Market (by Region), Value ($Million), 2023-2035 4.1 North America 4.1.1 Market Dynamics 4.1.2 Market Sizing and Forecast 4.1.3 North America Hepatitis D Market, by Country ($Million), 2023-2035 4.1.3.1</li>
<li>09, 2025 (GLOBE NEWSWIRE) -- The "Hepatitis D Market - A Global and Regional Analysis: Focus on Treatment Type, Diagnostic Method, and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarket</li>
<li>Key Topics Covered: 1.</li>
<li>Global Hepatitis D Market (by Treatment Type), Value ($million), 2023-2035 2.1 Antiviral Medications 2.2 Immunotherapies 2.3 Combination Therapies 3.</li>
<li>Hepatitis D Market Research Report 2023-2035 | Gilead, GSK, and Janssen Drive Innovation as Biotechs Advance Antivirals, RNA, and Gene Therapies The hepatitis D market is expanding due to increased diagnosis rates and ad</li>
</ul>
<p><a href="https://finance.yahoo.com/news/hepatitis-d-market-research-report-103500907.html">Source</a> · 2025-09-09T10:35:00+00:00</p>
</body>
</html>